Position in RCUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$24,052,159
-$4,800,105 QoQ
Shares Held
1,113,526
-8.0% QoQ
Ownership
0.885%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93.94966978768345.ToString("F0")%
Shared 0.ToString("F0")%
None 6.050330212316552.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. RCUS ranks #84 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in RCUS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,052,159 | 1,113,526 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,852,264 | 1,210,754 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $20,890,794 | 1,536,088 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $11,964,201 | 1,469,804 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $6,178,574 | 787,080 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,188,216 | 549,914 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $10,924,029 | 714,456 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $6,790,747 | 445,880 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $16,517,768 | 874,882 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $13,396,640 | 701,395 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $10,931,295 | 608,986 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $12,603,042 | 620,534 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,142,913 | 556,081 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,298,493 | 546,349 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,236,073 | 353,061 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,790,852 | 583,696 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $7,909,880 | 250,630 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $58,050,328 | 1,434,404 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,666,055 | 133,813 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,399,313 | 269,458 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $4,902,654 | 174,596 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,226,919 | 47,262 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $494,076 | 28,826 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,265,737 | 91,582 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $44,984 | 3,241 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||